Small intestinal transit time and intraluminal pH in ileocecal resected patients with Crohn's disease

Digestive Diseases and Sciences

Volumn 43, Issue 4, 1998, Pages 702-705

  Fallingborg, Jan ^a   Pedersen, Poul ^a   Jacobsen, Bent A ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Colon; Crohn's disease; pH; Small intestine

Indexed keywords

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL EXAMINATION; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; ILEUM RESECTION; INTESTINE RESECTION; INTESTINE TRANSIT TIME; MALE; PH MEASUREMENT; PRIORITY JOURNAL; SMALL INTESTINE;

ADULT; CAPSULES; CASE-CONTROL STUDIES; COLON; CROHN DISEASE; FEMALE; GASTRIC ACID; GASTROINTESTINAL TRANSIT; HUMANS; HYDROGEN-ION CONCENTRATION; ILEOCECAL VALVE; INTESTINE, SMALL; MALE;

EID: 0031946095     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018893409596     Document Type: Article

References (16)

1. Sasaki Y, Hada R, Nakajima H, Fukuda S, Munakata A: Improved localizing method of radiopill in measurement of entire gastrointestinal pH profiles: Colonic luminal pH in normal subjects and patients with Crohn's disease. Am J Gastroenterol 92:114-118, 1997
2. Munkholm P, Langholz E, Davidsen M, Binder V: Intestinal cancer risk and mortality in patients with Crohn's disease. Gastroenterology 105:1716-1723, 1993
3. Colson RH, Watson BW, Fairclough PD, Walker-Smith JA, Cambell CA, Bellamy D, Hinsull SM: An accurate, long-term, pH-sensitive radio pill for ingestion and implantation. Biotelemetry Patient Monit 8:213-227, 1981
4. Kholoussy AM, Yang Y, Bonacquisti K, Witkowski T, Takenaka K, Masumoto T: The competence and bacteriologic effect of the telescoped intestinal valve after small bowel resection. Am Surg 52:555-559, 1986
5. Ecker KW, Pistorius G, Harbauer G, Feifel G: Die bacterielle Clearance des terminalen Ileums in Abhangigkeit von der ileokolischen Konnektion. Zentralbl Chir 120:336-342, 1995
6. Fallingborg J, Christensen LA, Ingeman-Nielsen M, Jacobsen BA, Abildgaard K, Rasmussen HH: pH-profile and regional transit times of the normal gut measured by a radiotelemetry device. Aliment Pharmacol Ther 3:605-613, 1989
7. Evans DF, Pye G, Bramley R, Clark AG, Dyson TJ: Measurement of gastrointestinal pH profiles in normal ambulant human subjects. Gut 29:1035-1041, 1988
8. Hardy JG, Evans DF, Zaki I, Clarke AG, Tonnesen HH, Gamst ON: Evaluation of an enteric coated Naproxen tablet using gamma scintigraphy and pH monitoring. Int J Pharm 37:245-250, 1987
9. 2) breath test as compared with a radiological control method. Scand J Gastroenterol 21:669-677, 1986
10. Wilson CG, Parr CG, Kennerley JW, Taylor MJ, Davis SS, Hardy JG, Rees J: Pharmacokinetics and in vivo scintigraphic monitoring of a sustained release acetylsalicylic acid formulation. Int J Pharm 18:1-8, 1984
11. Greenberg GR, Feagan BG, Martin F, Sutherland LR, Thomson ABR, Williams CN, Nilsson L-G, Persson T, Canadian Inflammatory Bowel Disease Study Group: Oral budesonide for active Crohn's disease. N Engl J Med 331:836-841, 1994
12. Kloz U, Maier KE, Fischer C, Bauer KH: A new slow-release form of 5-aminosalicylic acid for the oral treatment of inflammatory bowel disease. Arzneim/Forsch Drug Res 35:636-639, 1985
13. McLeod RS, Cohen Z, Vari BJ, Blair JE, Greenberg GR: The release profile of a controlled release preparation of 5-aminosalicylic acid (Rowasa I) in humans. Dis Colon Rectum 33:21-25, 1990
14. Dew MW, Hughes PJ, Lee MG, Evans BK, Rhodes J: An oral preparation to release drugs in the human colon. Br J Clin Pharmacol 14:405-408, 1982
15. Dew MJ, Ryder REJ, Evans N, Evans BK, Rhodes J: Colonic release of 5-amino salicylic acid from an oral preparation in ulcerative colitis. Br J Clin Pharmacol 16:185-187, 1983
16. Stolk LML, Rietbroek R, Wiltink EH, Tukker JJ: Dissolution profiles of mesalazine formulations in vitro. Pharm Weekbl (Sci) 12:200-204, 1990